NIAID Banner Logo Image

Opportunistic Infections Citation List: June 7 - June 20, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Tentative Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole and Voriconazole for Six Candida Species Determined by the Colorimetric Sensititre YeastOne(R) Method. Canton, E., J. Peman, C. Iniguez, D. Hervas, J.L. Lopez-Hontangas, C. Pina-Vaz, J.J. Camarena, I. Campos-Herrero, I. Garcia-Garcia, A.M. Garcia-Tapia, R. Guna, P. Merino, L. Perez Del Molino, C. Rubio, and A. Suarez. Journal of Clinical Microbiology, 2013. [Epub ahead of print]. PMID[23761155].

[PubMed]. OI_0607-062013.


2. Synergistic Antifungal Activity of KB425796-C in Combination with Micafungin against Aspergillus fumigatus and Its Efficacy in Murine Infection Models. Kai, H., M. Yamashita, I. Nakamura, K. Yoshikawa, K. Nitta, M. Watanabe, N. Inamura, and A. Fujie. The Journal of Antibiotics, 2013. [Epub ahead of print]. PMID[23756682].

[PubMed]. OI_0607-062013.


3. Rationally Designed Transmembrane Peptide Mimics of the Multidrug Transporter Protein Cdr1 Act as Antagonists to Selectively Block Drug Efflux and Chemosensitize Azole-resistant Clinical Isolates of Candida albicans. Maurya, I.K., C.K. Thota, S.D. Verma, J. Sharma, M.K. Rawal, B. Ravikumar, S. Sen, N. Chauhan, A.M. Lynn, V.S. Chauhan, and R. Prasad. The Journal of Biological Chemistry, 2013. 288(23): p. 16775-16787. PMID[23592791].

[PubMed]. OI_0607-062013.


4. Biological Evaluation of Alginate-based Hydrogels, with Antimicrobial Features by Ce(III) Incorporation, as Vehicles for a Bone Substitute. Morais, D.S., M.A. Rodrigues, M.A. Lopes, M.J. Coelho, A.C. Mauricio, R. Gomes, I. Amorim, M.P. Ferraz, J.D. Santos, and C.M. Botelho. Journal of Materials Science: Materials in Medicine, 2013. [Epub ahead of print]. PMID[23756964].

[PubMed]. OI_0607-062013.


5. Preparative Thin Layer Chromatographic Separation Followed by Identification of Antifungal Compound in Cassia laevigata by RP-HPLC and GC-MS. Panigrahi, G., R. Maheshwari, V. Kumar, J. Prakash, S. Kumar, and J. Prabakaran. Journal of the Science of Food and Agriculture, 2013. [Epub ahead of print]. PMID[23749313].

[PubMed]. OI_0607-062013.


6. Activity of Four Antimicrobial Cocktails for Tissue Allograft Decontamination against Bacteria and Candida Spp. of Known Susceptibility at Different Temperatures. Pitt, T.L., K. Tidey, A. Roy, S. Ancliff, R. Lomas, and C.P. McDonald. Cell and Tissue Banking, 2013. [Epub ahead of print]. PMID[23765096].

[PubMed]. OI_0607-062013.


7. Antifungal Activity of the Lipopeptides Produced by Bacillus amyloliquefaciens anti-CA against Candida albicans Isolated from Clinic. Song, B., Y.J. Rong, M.X. Zhao, and Z.M. Chi. Applied Microbiology and Biotechnology, 2013. [Epub ahead of print]. PMID[23744287].

[PubMed]. OI_0607-062013.


8. Chemical Composition, Antimicrobial Properties and Toxicity Evaluation of the Essential Oil of Cupressus lusitanica Mill. Leaves from Cameroon. Teke, G.N., K.N. Elisee, and K.J. Roger. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 130. PMID[23758765].

[PubMed]. OI_0607-062013.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

9. Nonlytic Fc-fused IL-7 Synergizes with Mtb32 DNA Vaccine to Enhance Antigen-specific T Cell Responses in a Therapeutic Model of Tuberculosis. Ahn, S.S., B.Y. Jeon, S.J. Park, D.H. Choi, S.H. Ku, S.N. Cho, and Y.C. Sung. Vaccine, 2013. 31(27): p. 2884-2890. PMID[23624092].

[PubMed]. OI_0607-062013.


10. Identification, Biochemical and Structural Evaluation of Species-specific Inhibitors against Type I Methionine Aminopeptidases. Kishor, C., T. Arya, R. Reddi, X. Chen, V. Saddanapu, A.K. Marapaka, R. Gumpena, D. Ma, J.O. Liu, and A. Addlagatta. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23767698].

[PubMed]. OI_0607-062013.


11. A Novel Combinatorial Biocatalytic Approach for Producing Antibacterial Compounds Effective against Mycobacterium tuberculosis (Tb). McClay, K., B. Wan, Y. Wang, S. Cho, J. Yu, B. Santarsiero, S. Mehboob, M. Johnson, S. Franzblau, and R. Steffan. Applied Microbiology and Biotechnology, 2013. [Epub ahead of print]. PMID[23749163].

[PubMed]. OI_0607-062013.


12. Rifampicin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis with Specific rpoB-mutations. Rigouts, L., M. Gumusboga, W.B. de Rijk, E. Nduwamahoro, C. Uwizeye, B. de Jong, and A. Van Deun. Journal of Clinical Microbiology, 2013. [Epub ahead of print]. PMID[23761146].

[PubMed]. OI_0607-062013.


13. Synthesis and Antimycobacterial Evaluation of N-Substituted 5-chloropyrazine-2-carboxamides. Servusova, B., J. Vobickova, P. Paterova, V. Kubicek, J. Kunes, M. Dolezal, and J. Zitko. Bioorganic & Medicinal Chemistry Letters, 2013. 23(12): p. 3589-3591. PMID[23659859].

[PubMed]. OI_0607-062013.


14. Identification of a Small Molecule with Activity against Drug-resistant and Persistent Tuberculosis. Wang, F., D. Sambandan, R. Halder, J. Wang, S.M. Batt, B. Weinrick, I. Ahmad, P. Yang, Y. Zhang, J. Kim, M. Hassani, S. Huszar, C. Trefzer, Z. Ma, T. Kaneko, K.E. Mdluli, S. Franzblau, A.K. Chatterjee, K. Johnson, K. Mikusova, G.S. Besra, K. Futterer, W.R. Jacobs, Jr., and P.G. Schultz. Proceedings of the National Academy of Sciences of the United States of America, 2013. [Epub ahead of print]. PMID[23776209].

[PubMed]. OI_0607-062013.


15. Antituberculosis Thiophenes Define a Requirement for Pks13 in Mycolic acid Biosynthesis. Wilson, R., P. Kumar, V. Parashar, C. Vilcheze, R. Veyron-Churlet, J.S. Freundlich, S.W. Barnes, J.R. Walker, M.J. Szymonifka, E. Marchiano, S. Shenai, R. Colangeli, W.R. Jacobs, Jr., M.B. Neiditch, L. Kremer, and D. Alland. Nature Chemical Biology, 2013. [Epub ahead of print]. PMID[23770708].

[PubMed]. OI_0607-062013.


16. Fluoroquinolones for Treating Tuberculosis (Presumed Drug-sensitive). Ziganshina, L.E., A.F. Titarenko, and G.R. Davies. Cochrane Database of Systematic Reviews (Online), 2013. 6: p. CD004795. PMID[23744519].

[PubMed]. OI_0607-062013.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

17. UV-triggered Affinity-capture Identifies Interactions between the Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and Antimalarial Agents in Live Parasitized Cells. Brunner, R., C.L. Ng, H. Aissaoui, M.H. Akabas, C. Boss, R. Brun, P.S. Callaghan, O. Corminboef, I.J. Frame, B. Heidmann, A. Le Bihan, P. Jeno, C. Mattheis, S. Moes, I.B. Muller, M. Paguio, P.D. Roepe, R. Siegrist, T. Voss, R.W. Welford, S. Wittlin, D.A. Fidock, D.A. Fidock, and C. Binkert. The Journal of Biological Chemistry, 2013. [Epub ahead of print]. PMID[23754276].

[PubMed]. OI_0607-062013.


18. Antimalarial Activity of Cupredoxins: The Interaction of Plasmodium Merozoite Surface Protein 119 (MSP119) and Rusticyanin. Cruz-Gallardo, I., I. Diaz-Moreno, A. Diaz-Quintana, A. Donaire, A. Velazquez-Campoy, R.D. Curd, K. Rangachari, B. Birdsall, A. Ramos, A.A. Holder, and M.A. De la Rosa. The Journal of Biological Chemistry, 2013. [Epub ahead of print]. PMID[23749994].

[PubMed]. OI_0607-062013.


19. Anti-malarial Property of Steroidal Alkaloid Conessine Isolated from the Bark of Holarrhena antidysenterica. Dua, V.K., G. Verma, B. Singh, A. Rajan, U. Bagai, D.D. Agarwal, N. Gupta, S. Kumar, and A. Rastogi. Malaria Journal, 2013. 12(1): p. 194. PMID[23758861].

[PubMed]. OI_0607-062013.


20. Synthesis and Evaluation of Phenoxyoxazaphospholidine, Phenoxyoxazaphosphinane, and Benzodioxaphosphininamine sulfides and Related Compounds as Potential Anti-malarial Agents. Mara, C., E. Dempsey, A. Bell, and J.W. Barlow. Bioorganic & Medicinal Chemistry Letters, 2013. 23(12): p. 3580-3583. PMID[23659857].

[PubMed]. OI_0607-062013.


21. In Vitro Susceptibility to Quinine and Microsatellite Variations of the Plasmodium falciparum Na+/H+ Exchanger Transporter (Pfnhe-1) Gene in 393 Isolates from Dakar, Senegal. Pascual, A., B. Fall, N. Wurtz, M. Fall, C. Camara, A. Nakoulima, E. Baret, B. Diatta, K.B. Fall, P.S. Mbaye, Y. Dieme, R. Bercion, H. Bogreau, S. Briolant, C. Rogier, B. Wade, and B. Pradines. Malaria Journal, 2013. 12: p. 189. PMID[23758769].

[PubMed]. OI_0607-062013.

ANTIPROTOZOAL COMPOUNDS

22. Comparative Analysis of Anti-toxoplasmic Activity of Antipsychotic Drugs and Valproate. Fond, G., A. Macgregor, R. Tamouza, N. Hamdani, A. Meary, M. Leboyer, and J.F. Dubremetz. European Archives of Psychiatry and Clinical Neuroscience, 2013. [Epub ahead of print]. PMID[23771405].

[PubMed]. OI_0607-062013.

Citations from the ISI Web of Knowledge Listings for O.I.

23. Synthesis, Thermal Characterization, and Antimicrobial Activity of Lanthanum, Cerium, and Thorium Complexes of Amino Acid Schiff Base Ligand. Alghool, S., H.F. Abd El-Halim, M.S. Abd El-Sadek, I.S. Yahia, and L.A. Wahab. Journal of Thermal Analysis and Calorimetry, 2013. 112(2): p. 671-681. ISI[000318292400018].

[WOS]. OI_0607-062013.


24. Inhibition of Nuclear Factor-kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. Bai, X.Y., N.E. Feldman, K. Chmura, A.R. Ovrutsky, W.L. Su, L. Griffin, D. Pyeon, M.T. McGibney, M.J. Strand, M. Numata, S. Murakami, L. Gaido, J.R. Honda, W.H. Kinney, R.E. Oberley-Deegan, D.R. Voelker, D.J. Ordway, and E.D. Chan. PloS One, 2013. 8(4): p. e61925. ISI[000318341400027].

[WOS]. OI_0607-062013.


25. Three Antimycobacterial Metabolites Identified from a Marine-derived Streptomyces Sp MS100061. Chen, C.X., J. Wang, H. Guo, W.Y. Hou, N. Yang, B. Ren, M. Liu, H.Q. Dai, X.T. Liu, F.H. Song, and L.X. Zhang. Applied Microbiology and Biotechnology, 2013. 97(9): p. 3885-3892. ISI[000317681800012].

[WOS]. OI_0607-062013.


26. A Rational Approach to Identify Inhibitors of Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase. Chhabria, M.T., K.B. Parmar, and P.S. Brahmkshatriya. Current Pharmaceutical Design, 2013. 19(21): p. 3878-3883. ISI[000318687100012].

[WOS]. OI_0607-062013.


27. A Small Molecule Inhibitor of Fungal Histone Acetyltransferase Rtt109. da Rosa, J.L., V. Bajaj, J. Spoonamore, and P.D. Kaufman. Bioorganic & Medicinal Chemistry Letters, 2013. 23(10): p. 2853-2859. ISI[000318750000003].

[WOS]. OI_0607-062013.


28. A Novel Mechanistic Approach to Identify New Antifungal Lead Compounds Based on Amphotericin B Molecular Architecture. Ferdosian, M. and S. Sardari. Tropical Journal of Pharmaceutical Research, 2013. 12(2): p. 181-188. ISI[000318672800008].

[WOS]. OI_0607-062013.


29. The Canadian Medicinal Plant Heracleum maximum Contains Antimycobacterial Diynes and Furanocoumarins. O'Neill, T., J.A. Johnson, D. Webster, and C.A. Gray. Journal of Ethnopharmacology, 2013. 147(1): p. 232-237. ISI[000318386000024].

[WOS]. OI_0607-062013.


30. ApiAP2 Transcription Factor Restricts Development of the Toxoplasma Tissue Cyst. Radke, J.B., O. Lucas, E.K. De Silva, Y.F. Ma, W.J. Sullivan, L.M. Weiss, M. Llinas, and M.W. White. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(17): p. 6871-6876. ISI[000318677300062].

[WOS]. OI_0607-062013.


31. Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-Benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3. Remuinan, M.J., E. Perez-Herran, J. Rullas, C. Alemparte, M. Martinez-Hoyos, D.J. Dow, J. Afari, N. Mehta, J. Esquivias, E. Jimenez, F. Ortega-Muro, M.T. Fraile-Gabaldon, V.L. Spivey, N.J. Loman, M.J. Pallen, C. Constantinidou, D.J. Minick, M. Cacho, M.J. Rebollo-Lopez, C. Gonzalez, V. Sousa, I. Angulo-Barturen, A. Mendoza-Losana, D. Barros, G.S. Besra, L. Ballell, and N. Cammack. Plos One, 2013. 8(4) : p. e60933. ISI[000317907200017].

[WOS]. OI_0607-062013.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022